1072 related articles for article (PubMed ID: 28271032)
1. Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice.
Franko A; Neschen S; Rozman J; Rathkolb B; Aichler M; Feuchtinger A; Brachthäuser L; Neff F; Kovarova M; Wolf E; Fuchs H; Häring HU; Peter A; Hrabě de Angelis M
Mol Metab; 2017 Mar; 6(3):256-266. PubMed ID: 28271032
[TBL] [Abstract][Full Text] [Related]
2. Bezafibrate Improves Insulin Sensitivity and Metabolic Flexibility in STZ-Induced Diabetic Mice.
Franko A; Huypens P; Neschen S; Irmler M; Rozman J; Rathkolb B; Neff F; Prehn C; Dubois G; Baumann M; Massinger R; Gradinger D; Przemeck GK; Repp B; Aichler M; Feuchtinger A; Schommers P; Stöhr O; Sanchez-Lasheras C; Adamski J; Peter A; Prokisch H; Beckers J; Walch AK; Fuchs H; Wolf E; Schubert M; Wiesner RJ; Hrabě de Angelis M
Diabetes; 2016 Sep; 65(9):2540-52. PubMed ID: 27284107
[TBL] [Abstract][Full Text] [Related]
3. Bezafibrate on lipids and glucose metabolism in obese diabetic Otsuka Long-Evans Tokushima fatty rats.
Jia D; Yamamoto M; Otani M; Otsuki M
Metabolism; 2004 Apr; 53(4):405-13. PubMed ID: 15045684
[TBL] [Abstract][Full Text] [Related]
4. Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects.
Wang X; Liu R; Zhang W; Zhang X; Liao N; Wang Z; Li W; Qin X; Hai C
Mol Cell Endocrinol; 2013 Aug; 376(1-2):70-80. PubMed ID: 23791844
[TBL] [Abstract][Full Text] [Related]
5. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
6. Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome.
Sasaki Y; Shimada T; Iizuka S; Suzuki W; Makihara H; Teraoka R; Tsuneyama K; Hokao R; Aburada M
Eur J Pharmacol; 2011 Jul; 662(1-3):1-8. PubMed ID: 21549692
[TBL] [Abstract][Full Text] [Related]
7. Singular effects of PPAR agonists on nonalcoholic fatty liver disease of diet-induced obese mice.
Barbosa-da-Silva S; Souza-Mello V; Magliano DC; Marinho Tde S; Aguila MB; Mandarim-de-Lacerda CA
Life Sci; 2015 Apr; 127():73-81. PubMed ID: 25748419
[TBL] [Abstract][Full Text] [Related]
8. Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?
Tenenbaum A; Fisman EZ
Cardiovasc Diabetol; 2012 Nov; 11():140. PubMed ID: 23150952
[TBL] [Abstract][Full Text] [Related]
9. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice.
Park HS; Hur HJ; Kim SH; Park SJ; Hong MJ; Sung MJ; Kwon DY; Kim MS
Mol Nutr Food Res; 2016 Sep; 60(9):1944-55. PubMed ID: 27145114
[TBL] [Abstract][Full Text] [Related]
10. Myricitrin Ameliorates Hyperglycemia, Glucose Intolerance, Hepatic Steatosis, and Inflammation in High-Fat Diet/Streptozotocin-Induced Diabetic Mice.
Kim DY; Kim SR; Jung UJ
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182914
[TBL] [Abstract][Full Text] [Related]
11. Combination peroxisome proliferator-activated receptor gamma and alpha agonist treatment in Type 2 diabetes prevents the beneficial pioglitazone effect on liver fat content.
Balasubramanian R; Gerrard J; Dalla Man C; Firbank MJ; Lane A; English PT; Cobelli C; Taylor R
Diabet Med; 2010 Feb; 27(2):150-6. PubMed ID: 20546257
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice.
Brachs S; Winkel AF; Tang H; Birkenfeld AL; Brunner B; Jahn-Hofmann K; Margerie D; Ruetten H; Schmoll D; Spranger J
Mol Metab; 2016 Nov; 5(11):1072-1082. PubMed ID: 27818933
[TBL] [Abstract][Full Text] [Related]
13. Effect of Octreotide on Hepatic Steatosis in Diet-Induced Obesity in Rats.
Li M; Ye T; Wang XX; Li X; Qiang O; Yu T; Tang CW; Liu R
PLoS One; 2016; 11(3):e0152085. PubMed ID: 27002331
[TBL] [Abstract][Full Text] [Related]
14. Peri-conceptional obesogenic exposure induces sex-specific programming of disease susceptibilities in adult mouse offspring.
Dahlhoff M; Pfister S; Blutke A; Rozman J; Klingenspor M; Deutsch MJ; Rathkolb B; Fink B; Gimpfl M; Hrabě de Angelis M; Roscher AA; Wolf E; Ensenauer R
Biochim Biophys Acta; 2014 Feb; 1842(2):304-17. PubMed ID: 24275555
[TBL] [Abstract][Full Text] [Related]
15. Oxymatrine ameliorates non-alcoholic fatty liver disease in rats through peroxisome proliferator-activated receptor-α activation.
Shi L; Shi L; Zhang H; Hu Z; Wang C; Zhang D; Song G
Mol Med Rep; 2013 Aug; 8(2):439-45. PubMed ID: 23754536
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptors-alpha and gamma are targets to treat offspring from maternal diet-induced obesity in mice.
Magliano DC; Bargut TC; de Carvalho SN; Aguila MB; Mandarim-de-Lacerda CA; Souza-Mello V
PLoS One; 2013; 8(5):e64258. PubMed ID: 23700465
[TBL] [Abstract][Full Text] [Related]
17. Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet.
Fernandes-Santos C; Carneiro RE; de Souza Mendonca L; Aguila MB; Mandarim-de-Lacerda CA
Nutrition; 2009; 25(7-8):818-27. PubMed ID: 19268533
[TBL] [Abstract][Full Text] [Related]
18. The dual PPARalpha/gamma agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats.
Pickavance LC; Brand CL; Wassermann K; Wilding JP
Br J Pharmacol; 2005 Feb; 144(3):308-16. PubMed ID: 15655531
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin improves insulin resistance and hepatic steatosis in type 2 diabetes rats through activation of autophagy.
Zhou W; Ye S
Cell Biol Int; 2018 Sep; 42(10):1282-1291. PubMed ID: 29908010
[TBL] [Abstract][Full Text] [Related]
20. Adverse association between obesity and menopause in mice treated with bezafibrate, a pan peroxisome proliferator-activated receptor agonist.
Faria Tda S; Correia AL; dos Anjos TL; Aguila MB; Mandarim-de-Lacerda CA
Menopause; 2013 Dec; 20(12):1264-74. PubMed ID: 23632658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
